Novo Nordisk A/S ADR (USD)
NVO
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range65.82 | 66.66
52-Wk Range- | -
Last Close-
Mkt Cap (m)-
Dividend yield-
ISINUS6701002056
Volume208,694.00
Exchange VenueNYS

Company Profile

Novo Nordisk A/S is a healthcare company. It is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The company's business segments include, diabetes and obesity care, and biopharmaceuticals.

Key Information
Price/Earning-
Price/Book-
Price/Sales-
P/CF-
Rev Growth (3 year avg)2.97
EPS Growth (3 year avg)0.03
Operating Margin % 43.01
Net Margin %31.92
Return on Equity71.19
Debt/Equity0.08

Documents

Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

http://www.novonordisk.com

Financials

Income Statement
USD201420152016201720182019
Revenue (m)88,806.00107,927.00111,780.00111,696.00111,831.00122,021.00
Operating Income (m)34,492.0049,444.0048,432.0048,967.0047,248.0052,483.00
Net Income (m)26,481.0034,860.0037,925.0038,130.0038,628.0038,951.00
Basic EPS10.1013.5614.9915.4215.9616.41
Avg. Diluted Shares Outstanding (m)2,630.222,577.702,534.732,478.092,424.422,378.66
Balance Sheet
USD201420152016201720182019
Current Assets (m)46,293.0055,140.0059,766.0060,080.0059,067.0062,456.00
Non Current Assets (m)30,769.0036,659.0037,773.0042,275.0051,702.0063,156.00
Total Assets (m)77,062.0091,799.0097,539.00102,355.00110,769.00125,612.00
Current Liabilities (m)33,689.0040,873.0047,436.0047,056.0054,164.0058,983.00
Total Liabilities (m)------
Total Equity (m)40,294.0046,969.0045,269.0049,815.0051,839.0057,593.00
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)31,692.0038,287.0048,314.0041,168.0044,616.0046,782.00
Capital Expenditure (m)-4,335.00-6,406.00-8,267.00-8,648.00-12,410.00-11,231.00
Figures are quoted in USD unless stated otherwise
$
66.36
Last Price